Hostname: page-component-586b7cd67f-t8hqh Total loading time: 0 Render date: 2024-11-23T21:06:58.308Z Has data issue: false hasContentIssue false
  • English
  • Français

Myelin Basic Protein: A Component of Circulating Immune Complexes in Multiple Sclerosis

Published online by Cambridge University Press:  18 September 2015

Mrinal K. Dasgupta ,
Ingrid Catz ,
Kenneth G. Warren ,
Thomas A. McPherson ,
John B. Dossetor  and
Patrick R. Carnegie
Mrinal K. Dasgupta*
Affiliation:
Department of Medicine (Nephrology and Clinical Immunology), University of Alberta, Edmonton, Alberta
Ingrid Catz
Affiliation:
Cross Cancer Institute, Edmonton, Alberta
Kenneth G. Warren
Affiliation:
Department of Medicine (Neurology), University of Alberta, Edmonton, Alberta
Thomas A. McPherson
Affiliation:
Cross Cancer Institute, Edmonton, Alberta
John B. Dossetor
Affiliation:
Department of Medicine (Nephrology and Clinical Immunology), University of Alberta, Edmonton, Alberta
Patrick R. Carnegie
Affiliation:
Cross Cancer Institute, Edmonton, Alberta
*
Room 1046. University of Alberta Hospital, Edmonton, Alberta, Canada, T6G 2B7.
Rights & Permissions [Opens in a new window]

Summary:

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Myelin basic protein (MBP) is an antigenic component of circulating immune complexes (CIC) in patients with multiple sclerosis (MS). Immune complexes were isolated from the sera by adsorption to Raji cells and then acid eluted. Final identification of MBP from Raji eluates was done by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) followed by MBP radioimmunoassay (RIA) of gel eluates and by an immunoblot technique.

Type
Original Articles
Information
Canadian Journal of Neurological Sciences , Volume 10 , Issue 4 , November 1983 , pp. 239 - 243
Copyright
Copyright © Canadian Neurological Sciences Federation 1983

References

Alvord, E.C., Hruby, S., Sires, L.R. (1979). Degradation of myelin basic protein by cerebrospinal fluid: preservation of antigenic determinants under physiological conditions. Ann. Neurol. 6: 474–482.CrossRefGoogle ScholarPubMed
Carnegie, P.R., Dowse, C.A., Linthicum, D.S. (1983). Antigenic determinant recognized by a monoclonal antibody to myelin basic protein. J. Neuroimmunol., (in press).Google ScholarPubMed
Carson, J.H., Barbarese, E., Braun, P.E., McPherson, T.A. (1978). Components of multiple sclerosis cerebrospinal fluid that are detected by radioimmunoassay for myelin basic protein. Proc. Natl. Acad. Sci. USA 75, 1976–1978.CrossRefGoogle ScholarPubMed
Cohen, S.R., Herndon, R.M., McKhann, G.M. (1976). Radioimmunoassay of myelin basic protein in spinal fluid an index of active demyelination. New Engl. J. Med. 295: 1455–1457.CrossRefGoogle ScholarPubMed
Dasgupta, M.K., Warren, K.G., Johny, K.V., and Dossetor, J.B. (1982). Circulating immune complexes in multiple sclerosis: relation with disease activity. Neurology (Ny) 32: 1000–1004.CrossRefGoogle ScholarPubMed
Deicher, H., Schwabedissen, H.M., Liman, W., Baruth, B., Patzold, U., Haller, P. (1980). Immune complexes in cerebrospinal fluid and serum of patients with multiple sclerosis. In: Bauer, H.G., Poser, S., Ritter, G., eds. Progress in multiple sclerosis research. Verlag, Berlin: Springer, 200–206.CrossRefGoogle Scholar
Diebler, G.E., Martenson, R.C., Kies, M.W. (1972). Large scale preparation of myelin basic protein from central nervous tissue of several mammalian species. Prep. Biochem. 2: 139–165.Google Scholar
Goust, J.M., Chenais, F., Carnes, J.E., Hames, C.G., Fudenbergh, H.H., Hogan, H.L. (1978). Abnormal T cell subpopulations and circulating immune complexes in the Guillain-Barre syndrome and multiple sclerosis. Neurology (Ny) 28: 421–425.CrossRefGoogle ScholarPubMed
Gutstein, H.S. and Cohen, S.R. (1978). Spinal fluid differences in experimental allergic encephalomyelitis and multiple sclerosis. Science 199, 301–303.Google ScholarPubMed
Hsiung, H.M., Wu, J., McPherson, T.A. (1978). Silica gel radioimmunoassay for myelin basic protein. Clin. Biochem. 11: 54–56.CrossRefGoogle ScholarPubMed
Hunter, W.M., and Greenwood, F.C. (1962). Preparation of 131I labelled human growth hormone of high specific activity. Nature 195: 495–496.CrossRefGoogle Scholar
Jacques, C., Davous, P., Baumann, N. (1977). Circulating immune complexes and multiple sclerosis. Lancet 2: 408.CrossRefGoogle Scholar
Jans, H., Jersild, C., Taaning, E., Dybkjaer, E., Fog, T., Heltberg, A. (1980). The occurrence of immune complexes in patients with multiple sclerosis. In: Bauer, H.G., Poser, S., Ritter, G., eds. Progress in multiple sclerosis research. Verlag, Berlin: Springer, 195–199.Google Scholar
Johny, K.V., Dasgupta, M.K., Nakashima, S., Dossetor, J.B. (1981). Three polyethylene glycol dependent methods for the detection of circulating immune complexes in pathological sera: comparison with the Raji cell method. J. Immunol. Methods 40: 61–71.CrossRefGoogle ScholarPubMed
Koh, S.C., Tsukada, N., Yanagisawa, N., Kunishita, T., Uemura, K.Taketomi, T. (1981). Mild encephalitogenic activity of basic protein-acidic lipid complex from myelin and detection of immune complexes in experimental allergic encephalomyelitis. J. Neuroimmunology 1: 69–80.CrossRefGoogle ScholarPubMed
Lisak, R.P. and Zweiman, B. (1977). In vitro cell mediated immunity of cerebrospinal fluid lymphocytes to myelin basic protein in primary demyelinating disease. New Engl, J. Med. 297: 850–853.Google Scholar
Mason, D.Y., Sammons, R. (1978). Alkaline phosphatase and peroxidase for double immunoenzymatic labelling of culture constituents. J. Clin. Path. 31: 454–460.CrossRefGoogle Scholar
McFarlin, D.E., Hsu, S.C.L., Slemenda, S.B., Chou, F.C.H. and Kibler, R.F. (1975). The immune response against myelin basic protein in two strains of rat with different genetic capacity to develop experimental allergic encephalomyelitis. J. Exp. Med. 141: 72–81.CrossRefGoogle Scholar
McPherson, T.A., Gilpin, A., Seland, T.P. (1972). Radioimmunoassay of CSF for encephalitogenic basic protein. Can. Med. Assn. J. 107: 856–859.Google ScholarPubMed
Noronha, A.B.C., Antel, J.P., Roos, R.P., Medof, E.M. (1981). Circulating immune complexes in neurologic disease. Neurology 31: 1402–1407.CrossRefGoogle ScholarPubMed
Palfreyman, J.W., Thomas, G.T., Ratcliffe, J.G. (1978). Radioimmunoassay of human myelin basic protein in tissue extract, cerebrospinal fluid and serum and its clinical application to patients with head injury. Clin. Chem. Acta 82: 259.CrossRefGoogle ScholarPubMed
Panitch, H.S., Hafler, D.A., Johnson, K.P. (1980). Antibodiestomyelin basic protein in cerebrospinal fluid of patients with multiple sclerosis. In: Bauer, H.J., Poser, S.R., Ritter, G., Eds. Progress in Multiple Sclerosis Research. Springer-Verlag, Berlin. Heidelberg, New York, pp. 98–105.CrossRefGoogle Scholar
Paterson, P. Y. (1976). Experimental autoimmune (allergic) encephalomyelitis: induction, pathogenesis and suppression, in Textbook of Immunopathology. (Second Edn) Meischer, P.A., Muller-Eberherd, J.J. (eds). Grune & Stratton. New York. Vol I. 179–213.Google Scholar
Paterson, P.Y. (1978). The demyelinating diseases: clinical and experimental studies in animals and man. In: Immunological Diseases Santer, M.. Ed., Little Brown Co., USA., Vol. II. 1406–1419.Google Scholar
Paterson, P.Y., and Day, E.D. (1982). Current perspectives of neuroimmunologic diseases: MS and experimental allergic encephalomyelitis. Clin. Immunol. Rev I: 581–697.Google Scholar
Raine, C.S., Snyder, D.H., Valsamis, M.P., Stone, S.H. (1974). Chronic experimental allergic encephalomyelitis in inbred guinea pigs: an ultrastructural study. Lab. Invest. 31: 369–380.Google ScholarPubMed
Rose, A.S., Ellison, G.W., Myers, L.W., Tourtellotte, W.W.Criteria for the clinical diagnosis of multiple sclerosis. Neurology 1976: 26 (part 2): 20–22.Google Scholar
Schocket, A.L., Carr, R.I., Hardtke, M. A. (1980). A comparison of 125I Clq binding, Raji cell binding and lymphocytotoxic activity in multiple sclerosis. Clin. Immunol. Immunopathol. 17: 477–481.CrossRefGoogle Scholar
Tachovsky, T.G., Lisak, R.P., Koprowski, H.,Theofilopoulos, A.N., Dixon, F.J. (1976). Circulating immune complexes in multiple sclerosis and other neurological diseases. Lancet 2: 997–999.CrossRefGoogle ScholarPubMed
Theofilopoulos, A.N., Eisenberg, R.A., Dixon, F.J. (1978). Isolation of circulating immune complexes using Raji cells: separation of antigens from immune complexes and production of anti-serum. J. Clin. Invest. 61: 1570–1581.CrossRefGoogle Scholar
Theofilopoulos, A.N., Wilson, C.B. and Dixon, F.J. (1976). The Raji cell radioimmunoassay for detection of circulating immune complexes. J. Clin. Invest. 57: 169–182.CrossRefGoogle Scholar
Trouillas, P., Vincent, C., Revillard, J. V.(1980). Clq binding circulating immune complexes in multiple sclerosis patients and their first degree relatives: a distinctive immunological feature between sporadic and familial cases. J. Clin. Lab. Immunol. 4: 77–81.Google ScholarPubMed
Whitaker, J.N. (1975). The antigenicity of myelin basic protein: production of antibodies to encephalitogenic protein with DN A-encephalitogenic protein complexes. J. Immunol. 114: 823–830.CrossRefGoogle Scholar
Whitaker, J.N. (1977). Myelin encephalitogenic protein fragments in cerebrospinal fluid of persons with multiple sclerosis. Neurology 27: 911–920.CrossRefGoogle ScholarPubMed